Table 3. List of biological pathways affected by phenylalanine or valine treatment.
| Detected pathway | Phenylalanine | Valine |
|---|---|---|
| Alzheimer disease-presenilin pathway | •1) | • |
| Angiogenesis | • | |
| Apoptosis signaling pathway | • | |
| ATP synthesis | • | • |
| Cadherin signaling pathway | • | • |
| Cholecystokinin receptor signaling map | • | • |
| Cytoskeletal regulation by Rho GTPase | • | • |
| De novo purine biosynthesis | • | • |
| De novo pyrimidine deoxyribonucleotide biosynthesis | • | • |
| De novo pyrimidine ribonucleotides biosynthesis | • | • |
| Dopamine receptor mediated signaling pathway | • | |
| Epidermal growth factor receptor signaling pathway | • | • |
| Fibroblast growth factor signaling pathway | • | • |
| Fructose galactose metabolism | • | |
| Glycolysis | • | • |
| Gonadotropin-releasing hormone receptor pathway | • | • |
| Huntington disease | • | • |
| Integrin signaling pathway | • | • |
| Nicotine pharmacodynamics pathway | • | |
| p38 mitogen-activated protein kinase pathway | • | |
| p53 pathway | • | • |
| Parkinson disease | • | • |
| Pentose phosphate pathway | • | |
| PI3 kinase pathway | • | |
| Salvage pyrimidine ribonucleotides | • | • |
| Vascular endothelial growth factor signaling pathway | • | |
| Wnt signaling pathway | • | • |
Pathway analysis was performed using PANTHER (http://www.pantherdb.org).
Affected pathways after phenylalanine or valine treatment.